SARS-CoV-2: a storm is raging

Cited by (1,000)

Items 201–300 of 1,000

1. Sphingolipids as Modulators of SARS-CoV-2 Infection
   Kid Törnquist, Muhammad Yasir Asghar, Vignesh Srinivasan, Laura Korhonen, Dan Lindholm · 2021 · Frontiers in Cell and Developmental Biology
2. Incorrect Facemask-Wearing Detection Using Convolutional Neural Networks with Transfer Learning
   Jesús Tomás, Albert Rego, Sandra Viciano-Tudela, Jaime Lloret · 2021 · Healthcare
3. Tip of the iceberg: erectile dysfunction and COVID-19
   Mehmet Kaynar, Ana Luísa Quinta-Gomes, Ioannis Sokolakis, Murat Gül · 2022 · International Journal of Impotence Research
4. Tocilizumab and COVID-19: Timing of Administration and Efficacy
   Emna Abidi, Wasim S. El Nekidy, Eman A. Alefishat, Nadeem Rahman, Georg A. Petroianu, Rania M. El-Lababidi, Jihad Mallat · 2022 · Frontiers in Pharmacology
5. Be aware of acute kidney injury in critically ill children with COVID-19
   Xiaowen Wang, Xingfeng Chen, Feng Tang, Wanjun Luo, Jian Fang, Chang Qi, Hua Ling Sun, Xiao Han, Xuehua Peng, Jianbo Shao · 2020 · Pediatric Nephrology
6. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
   Vladimir Nikolaevich Uversky, Fatma Elrashdy, Abdullah A. Aljaddawi, Syed Moasfar Ali, Rizwan Hasan Khan, Elrashdy M Moustafa Mohamed Redwan · 2020 · Journal of Neuroscience Research
7. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2
   Abul Bashar Mir Md. Khademul Islam, Md. Abdullah‐Al‐Kamran Khan, Rasel Ahmed, Md. Sabbir Hossain, Shah Md Tamim Kabir, Md. Shahidul Islam, AMAM Zonaed Siddiki · 2021 · Journal of Translational Medicine
8. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection
   Marc A. Niles, Patricia Gogesch, Stefanie Kronhart, Samira Ortega Iannazzo, Georg Kochs, Zoe Waibler, Martina Anzaghe · 2021 · Frontiers in Immunology
9. A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
   Binsheng He, Fangxing Hou, Changjing Ren, Pingping Bing, Xiao Xiangzuo · 2021 · Frontiers in Oncology
10. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics
    Leena Sapra, Chaman Saini, Bhavuk Garg, Ranjan Gupta, Bhupendra Verma, Pradyumna Kumar Mishra, Rupesh Kumar Srivastava · 2022 · Inflammation Research
11. Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review
    Habib Haybar, Khalil Kazemnia, Fakher Rahim · 2020 · Jundishapur Journal of Chronic Disease Care
12. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
    Caroline Ruetsch-Chelli, Vesna Brglez, Marion Crémoni, Kévin Zorzi, Céline Fernandez, Sonia Boyer‐Suavet, Sylvia Benzaken, Élisa Demonchy, Karine Risso, Johan Courjon et al. · 2021 · Frontiers in Medicine
13. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
    Mehran Ghasemzadeh, Alireza Ghasemzadeh, Ehteramolsadat Hosseini · 2021 · Human Immunology
14. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
    Himanshu Agrawal, Neeladrisingha Das, Sandip Nathani, Sarama Saha, Surendra Kumar Saini, Sham S. Kakar, Partha Roy · 2020 · Stem Cell Reviews and Reports
15. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
    Constant Gillot, Julien Favresse, François Mullier, Thomas Lecompte, Jean‐Michel Dogné, Jonathan Douxfils · 2021 · Frontiers in Pharmacology
16. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
    Nianping Liu, Chen Jiang, Pengfei Cai, Zhuoqiao Shen, Wujianan Sun, Hao Ying Xu, Minghao Fang, Xinfeng Yao, Lin Zhu, Xuyuan Gao et al. · 2021 · Cell Reports
17. Comprehensive Landscape of Heparin Therapy for COVID-19
    Chen Shi, Tingting Wu, Jin-Ping Li, Mitchell Anthony Sullivan, Cong Wang, Hanxiang Wang, Bin Deng, Yu Zhang · 2020 · Carbohydrate Polymers
18. Wildland firefighter exposure to smoke and COVID-19: A new risk on the fire line
    Kathleen M. Navarro, Kathleen A. Clark, Daniel J. Hardt, Colleen E. Reid, Peter W. Lahm, Joseph W. Domitrovich, Corey Butler, John Randolph Balmes · 2020 · The Science of The Total Environment
19. Neutrophil Extracellular Traps: New Aspects
    N.V. Vorobjeva · 2020 · Moscow University Biological Sciences Bulletin
20. A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19
    Xiaobo Zhang, Rui Gao, Zubing Zhou, Xuehua Tang, Jingjing Lin, Long Wang, Xin Hua Zhou, Tao Shen · 2021 · International Journal of Medical Sciences
21. Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19
    Ting Lu, Rui Ma, Wen-Juan Dong, Kun-Yu Teng, Daniel S. Kollath, Zhi-Yao Li, Jinhee Yi, C. Bustillos, Shou-Bao Ma, L. Tian et al. · 2022 · Nature Communications
22. Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19
    Wei Xia, Yafeng Tan, Sheng-Juan Hu, Cheng-Bin Li, Tao Jiang · 2022 · Clinical and applied thrombosis/hemostasis
23. Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications
    Gianmaria Salvio, Claudio Gianfelice, Francesca Firmani, Stefano Lunetti, Giancarlo Balercia, Gilberta Giacchetti · 2020 · Clinical Reviews in Bone and Mineral Metabolism
24. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
    Jun-Gyu Park, Fatai S. Oladunni, Mohammed A. Rohaim, Jayde Whittingham‐Dowd, James Tollitt, Matt Hodges, Nadin Fathallah, Mushref Bakri Assas, Wafaa Ahmed Alhazmi, Abdullah Almilaibary et al. · 2021 · iScience
25. IL-15 immunotherapy is a viable strategy for COVID-19
    Hemanth Kumar Kandikattu, Sathisha Upparahalli Venkateshaiah, Sandeep Kumar, Anil Mishra · 2020 · Cytokine & Growth Factor Reviews
26. Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2
    Anup Masih, Amol K. Agnihotri, Jitendra Kumar Srivastava, Nidhi Pandey, Hans Raj Bhat, Udaya Pratap Singh · 2020 · Journal of Biochemical and Molecular Toxicology
27. SARS-CoV-2 Infection in the Central Nervous System of a 1-Year-Old Infant Submitted to Complete Autopsy
    Gomes, Ismael Carlos, Karmirian, Karina, Oliveira, Julia, Pedrosa, Carolina, Rosman, Fernando Colonna, Chimelli, Leila, Rehen, Stevens · 2020
28. In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
    Giulia Lo Russo, Marzio Alfio Pennisi, Epifanio Fichera, Santo Motta, Giuseppina Raciti, Marco Viceconti, Francesco Pappalardo · 2020 · BMC Bioinformatics
29. Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
    Fatih Haşlak, Mehmet Yıldız, Amra Adroviç, Sezgin Şahin, Oya Köker, Ayten Aliyeva, Kenan Barut, Özgür Kasapçopur · 2020 · Rheumatology International
30. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It
    Stefano Cappanera, Michele Palumbo, Sherman H. Kwan, Giulia Priante, Lucia Assunta Martella, Lavinia Maria Saraca, Francesco Sicari, Carlo Vernelli, Cinzia Di Giuli, P. Andreani et al. · 2021 · Journal of Clinical Medicine
31. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients
    Joaquim Bosch‐Barrera, Begoña Martı́n-Castillo, María Buxó, Joan Brunet, José Antonio Encinar, Javier Abel Menéndez · 2020 · Journal of Clinical Medicine
32. Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements
    K. S. Jagannatha Rao, Suryaprakash Vaddi, Rajappa Senthilkumar, Senthilkumar Preethy, Shojiro Katoh, Nobunao Ikewaki, Samuel JK Abraham · 2020 · Frontiers in Immunology
33. Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19
    De Chang, Peng Zhao, Dawei Zhang, Jinghui Dong, Zhe Xu, Guang Yang, Boyu Li, Hongxia Liu, Boan Li, Cheng‐Feng Qin et al. · 2020 · The Journal of Allergy and Clinical Immunology In Practice
34. Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
    Madalina Elena Carter-Timofte, Sofie E. Jørgensen, Mette Ratzer Freytag, Michelle M. Thomsen, Nanna-Sophie Brinck Andersen, Ali Al-Mousawi, Alon Schneider Hait, Trine Hyrup Mogensen · 2020 · Frontiers in Immunology
35. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
    Jamie Nicole Justice, Sriram Gubbi, Ameya S Kulkarni, Jenna M. Bartley, George A. Kuchel, Nir Barzilai · 2020 · GeroScience
36. IL-6 modulation for COVID-19: the right patients at the right time?
    Paolo A. Ascierto, Binqing Fu, Haiming Wei · 2021 · Journal for ImmunoTherapy of Cancer
37. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19
    Ilario De Toma, Mara Dierssen · 2021 · Scientific Reports
38. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity
    Amin, Saiful, Aktar, Salma, Rahman, Md. Mijanur, Chowdhury, Mohammed Mehadi Hassan · 2022 · Microbes and Infection
39. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks
    Alexander M. Tatara · 2020 · Tissue Engineering Part A
40. Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19
    Ran Jia, Xiangshi Wang, Pengcheng Liu, Xiaozhen Liang, Yanling Ge, He Tian, Hailing Chang, Hao Zhou, Mei Zeng, Jin Xu · 2020 · Virologica Sinica
41. Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions
    Charles Awortwe, Ingolf Cascorbi · 2020 · Pharmacological Research
42. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 – A systematic review, meta-analysis, and meta-regression
    Emir Yonas, Idrus Alwi, Raymond Pranata, Ian Huang, Michael Anthonius Lim, Muhammad Yamin, Sally Aman Nasution, Siti Setiati, Salim S. Virani · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
43. Empowering Children Through School Re-Entry Activities After the COVID-19 Pandemic
    Michele Capurso, John L. Dennis, Luciana Pagano Salmi, Cristina Parrino, Claudia Mazzeschi · 2020 · Continuity in Education
44. Epigenetic mechanisms influencing COVID-19
    Rwik Sen, Michael R. Garbati, Kevin F. Bryant, Yanan Lu · 2021 · Genome
45. Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
    Giovanna Giovinazzo, C. Gerardi, Caterina Uberti‐Foppa, Lucia Lopalco · 2020 · Molecules
46. Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer
    Remy J.H. Martens, Arjan J. van Adrichem, Nadine J.A. Mattheij, Calvin G. Brouwer, Daan J.L. van Twist, Jasper J. C. R. Broerse, César Magro Checa, Christel M. P. van Dongen, Rémy L.M. Mostard, Sofía Ramiro et al. · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
47. Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
    Hacer Kuzu Okur, Koray Yalçın, Cihan Taştan, Sevda Demir, Bulut Yurtsever, Gözde Sır Karakuş, Derya Dilek Kançağı, Selen Abanuz, Utku Seyis, Rehile Zengin et al. · 2020 · New Microbes and New Infections
48. A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2
    Arif Kıvrak, Berdan Ulaş, Hilal Kıvrak · 2020 · International Immunopharmacology
49. The relationship between COVID-19 and the dental damage stage determined by radiological examination
    Dursun Ali Şirin, Fatih Özçelik · 2021 · Oral Radiology
50. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19
    Javier Abel Menéndez · 2020 · Aging
51. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
    Franco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, Loris Riccardo Lopetuso, Lorenzo Maria Vetrone, Valentina Petito, Daniela Pugliese, Matteo Neri, Giovanni Cammarota, Yehuda Ringel et al. · 2020 · Inflammatory Bowel Diseases
52. Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients
    Rasha Abu Eid, Frank James Ward · 2021 · Immunology Letters
53. Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
    Priyanka Pahan, Kalipada Pahan · 2020 · Journal of Neuroimmune Pharmacology
54. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19
    Bruno Tilocca, Alessio Soggiù, Maurizio Sanguinetti, Gabriele Babini, Flavio De Maio, Domenico Britti, Alfonso Zecconi, L. Bonizzi, Andrea Urbani, Paola Roncada · 2020 · Microbes and Infection
55. Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China
    Hui Tang, Jian-Bo Tian, Jun-Wu Dong, Xiao-Tie Tang, Zhen-Yuan Yan, Yuanyuan Zhao, Fei Xiong, Xin Sun, Cai-Xia Song, Chang-Gang Xiang et al. · 2020 · American Journal of Kidney Diseases
56. Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review
    Morteza Izadi, Luca Cegolon, Mohammad Javanbakht, Ali Sarafzadeh, Hassan Abolghasemi, Gholam Hossein Alishiri, Shi Zhao, Behzad Einollahi, Mandana Kashaki, Nematollah Jonaidi Jafari et al. · 2020 · International Immunopharmacology
57. Mapping the SARS-CoV-2–Host Protein–Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics
    Rosa Terracciano, Mariaimmacolata Preianò, Annalisa Fregola, Corrado Pelaia, Tiziana Montalcini, Rocco Savino · 2021 · International Journal of Molecular Sciences
58. Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines
    Julio Villena, Chang Li, María Guadalupe Vizoso-Pinto, Jacinto Sacur, Linzhu Ren, Haruki Kitazawa · 2021 · Microorganisms
59. Coronavirus: A possible cause of reduced male fertility
    Chuan Huang, Xi‐Ren Ji, Wen‐Jun Zhou, Zhenghui Huang, Xiangjie Peng, Liqing Fan, Ge Lin, Wenbing Zhu · 2020 · Andrology
60. Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation
    Rebeca Nunes Silva, Cássia da Luz Goulart, Murilo Rezende Oliveira, Guilherme Yassuyuki Tacao, Guilherme Dionir Back, Richard S. Severin, Mark A. Faghy, Ross A Arena, Audrey Borghi‐Silva · 2021 · Expert Review of Respiratory Medicine
61. Performance of early warning signals for disease re-emergence: A case study on COVID-19 data
    Daniele Proverbio, Françoise Kemp, Stefano Magni, Jorge M. Gonçalves · 2022 · PLoS Computational Biology
62. COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings
    Recep Öztürk, Yeşim Taşova, Akif Ayaz · 2020 · TURKISH JOURNAL OF MEDICAL SCIENCES
63. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)
    Cristina Mussini, Marco Falcone, Silvia Nozza, Caterina Sagnelli, Roberto Parrella, Marianna Meschiari, Nicola Petrosillo, Claudio Maria Mastroianni, Antonio Cascio, Chiara Iaria et al. · 2021 · Clinical Microbiology and Infection
64. Prognostic bioindicators in severe COVID-19 patients
    Laura Bergantini, Elena Bargagli, Miriana d’Alessandro, Rosa Metella Refini, Paolo Cameli, Lucrezia Galasso, Carlo Scapellato, Francesca Montagnani, Sabino Scolletta, Federico Franchi et al. · 2021 · Cytokine
65. Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
    Shetty Ravi Dyavar, Rahul Singh, Rohini Emani, Ganesh P. Pawar, Vinod D. Chaudhari, Anthony T. Podany, Sean N. Avedissian, Courtney Vail Fletcher, Deepak B. Salunke · 2021 · Biomedicine & Pharmacotherapy
66. COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions
    E. Urano, T. Okamura, Chikako Ono, Shiori Ueno, S. Nagata, H. Kamada, Mahoko Higuchi, Mugi Furukawa, W. Kamitani, Y. Matsuura et al. · 2021 · Proceedings of the National Academy of Sciences of the United States of America
67. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues
    Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur, Hiroko Matsui, Agnieszka D’Antonio‐Chronowska, Kelly A. Frazer, Benjamin M. Neale, Mark J. Daly, Andrea Ganna, Christine R. Stevens et al. · 2021 · Cell Reports
68. The potential role of the carotid body in COVID-19
    Andrea Porzionato, Aron Emmi, Elena Stocco, Silvia Barbon, Rafael Boscolo-berto A, Veronica Macchi, Raffaele De · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
69. Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis
    Israël Vlodavsky, Uri Barash, Hien M. Nguyen, Shiming Yang, Neta Ilan · 2021 · Seminars in Thrombosis and Hemostasis
70. Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsis
    Sheng-yuan Zhang, Qiuping Xu, Li-na Shi, Shih-wen Li, Weihong Wang, Qingqing Wang, Liaoxun Lu, Hui Qing Xiao, Jun-hong Wang, Fengying Li et al. · 2023 · Signal Transduction and Targeted Therapy
71. 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
    Ana Cristina Simões e Silva, Katharina Lanza, Vitória Andrade Palmeira, Larissa Braga Costa, Joseph T. Flynn · 2020 · Pediatric Nephrology
72. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
    Cristina Cerqueira Vieira, Lucas Nery, Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Raphael Figuiredo Dias, Ana Cristina Simões e Silva · 2020 · Current Drug Targets
73. Predictive immunogenetic markers in COVID-19
    Mauro de Meira Leite, Faviel F. González-Galarza, Bruno Conde Costa da Silva, Derek Middleton, Eduardo José Melo dos Santos · 2021 · Human Immunology
74. Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans
    Jennifer M. Rudd, Miruthula Tamil Selvan, Shannon R. Cowan, Yun-Fan Kao, Cecily C. Midkiff, Sai Sankara Narayanan, Akhilesh Ramachandran, Jerry W. Ritchey, Craig Miller · 2021 · Viruses
75. Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study
    Xunliang Tong, Anqi Cheng, Xueting Yuan, Xuefeng Zhong, He Wang, Wei Zhou, Xiaomao Xu, Yanming Li · 2021 · BMC Infectious Diseases
76. SARS-CoV-2 Infection and the Liver
    Katie Morgan, Kay Samuel, Martin Vandeputte, Peter Clive Hayes, John N. Plevris · 2020 · Pathogens
77. Revisiting potential druggable targets against SARS‐CoV ‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
    Abdullah Al Mamun Sohag, Md. Abdul Hannan, Sadaqur Rahman, Motaher Hossain, Mahmudul Hasan, Md Kawsar Khan, Amena Khatun, Raju Dash, Md Jamal Uddin · 2020 · Drug Development Research
78. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review
    Sara Tomerak, Safah Khan, Muna Almasri, Rawan Hussein, Ali A. Abdelati, Ahmed Mohamed Aly, Mohammad A. Salameh, Arwa Saed Aldien, Hiba Naveed, Mohamed Badreldin Elshazly et al. · 2021 · Scandinavian Journal of Immunology
79. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection
    Ying Luo, Liyan Mao, Yuan Xu, Ying Xue, Qun Lin, Guoxing Tang, Huijuan Song, Feng Wang, Ziyong Sun · 2020 · Journal of Clinical Immunology
80. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges
    Gholam Reza Sivandzadeh, Hassan Askari, Ali Reza Safarpour, Fardad Ejtehadi, Ehsan Raeis-Abdollahi, Armaghan Vaez LARI, Mohammad Foad Abazari, Firoozeh Tarkesh, Kamran Bagheri Lankarani · 2021 · World Journal of Clinical Cases
81. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2
    Sudhanshu Agrawal, Jon V. Salazar, Thu Michelle Tran, Anshu Agrawal · 2021 · Frontiers in Immunology
82. COVID-19 and Its Repercussions on Oral Health: A Review
    Laura Cristina Rusu, Lavinia Cosmina Ardelean, Codruța Victoria Țigmeanu, Anamaria Matichescu, Iulia Sauciur, Emanuel Adrian Bratu · 2021 · Medicina
83. Ensemble Deep Learning Derived from Transfer Learning for Classification of COVID-19 Patients on Hybrid Deep-Learning-Based Lung Segmentation: A Data Augmentation and Balancing Framework
    Arun Kumar Dubey, Gian Luca Chabert, Alessandro Carriero, Alessio Paschè, Pietro S. C. Danna, Sushant Agarwal, Lopamudra Mohanty, Nillmani, Neeraj Sharma, Sarita Yadav et al. · 2023 · Diagnostics
84. Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
    Evgeny Lvovich Nasonov, Tatiana Valentinovna Beketova, Tatiana Magomedalievna Reshetnyak, Aleksander M. Lila, L. Ananieva, Tatyana Andreyevna Lisitsyna, S. K. Soloviev · 2020 · Rheumatology Science and Practice
85. Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation
    Chengliang Yang, Shaf H Keshavjee, Mingyao Liu · 2020 · Frontiers in Pharmacology
86. HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
    Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi, Andrea Stevenazzi, Barbara Vergani, Mattia Marchini, Giovanni Sandrone, Emanuele Bonetti, Luca Mazzarella, Saverio Minucci et al. · 2022 · Frontiers in Immunology
87. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
    Vijay Kumar · 2020 · International Immunopharmacology
88. Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19
    Rosa Bellmann‐Weiler, Lukas Lanser, Francesco Robert Burkert, Stefanie Seiwald, Gernot Fritsche, Sophie Maria Wildner, Andrea Schroll, Sabine Koppelstätter, Katharina Kurz, Andrea Griesmacher et al. · 2020 · Open Forum Infectious Diseases
89. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
    Georgina M. Ellison, Liam Sean Colley, Katie A. O’Brien, Kirsty A. Roberts, Thomas A. Agbaedeng, Mark Ross · 2020 · Frontiers in Cardiovascular Medicine
90. Real-time measurement of the uncertain epidemiological appearances of COVID-19 infections
    Meenu Gupta, Rachna Jain, Soham Taneja, Gopal Chaudhary, Manju Khari, Elena Verdú · 2020 · Applied Soft Computing
91. Interleukin-6 blocking agents for treating COVID-19: a living systematic review
    Lina Ghosn, Rouba Assi, Theodoros Evrenoglou, Brian S Buckley, Nicholas Henschke, Katrin Probyn, Carolina Riveros, Mauricia Davidson, Carolina Graña, Hillary Bonnet et al. · 2023 · Cochrane Database of Systematic Reviews
92. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
    Donovan Anthony McGrowder, Fabian G. Miller, Melisa Anderson Cross, Lennox Anderson-Jackson, Sophia Bryan, Lowell Dilworth · 2021 · Diseases
93. Aloe polymeric acemannan inhibits the cytokine storm in mouse pneumonia models by modulating macrophage metabolism
    Lu Li, Weijie Xu, Yinzhu Luo, Chunqin Lao, Xueli Tong, Junxi Du, Bihong Huang, Di Li, Jingmian Chen, Huiling Ye et al. · 2022 · Carbohydrate Polymers
94. Pharmacokinetics of a single inhalation of hydrogen gas in pigs
    Motoaki Sano, Genki Ichihara, Yoshinori Katsumata, Takahiro Hiraide, Akeo Hirai, Mizuki Momoi, Tomoyoshi Tamura, Shigeo Ohata, Eiji Kobayashi · 2020 · PLoS ONE
95. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS
    David S. Perlin, Inbal Zafir‐Lavie, Lori Roadcap, Shane R. Raines, Carl F. Ware, Garry A. Neil · 2020 · mSphere
96. How SARS-CoV-2 (COVID-19) spreads within infected hosts — what we know so far
    Sumana Sanyal · 2020 · Emerging Topics in Life Sciences
97. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
    Béhazine Combadière, Lucille Adam, Noëlline Guillou, Paul Quentric, Pierre Rosenbaum, Karim Dorgham, Olivia Bonduelle, Christophe Parizot, Delphine Sauce, Julien Mayaux et al. · 2021 · Frontiers in Immunology
98. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19
    Hao Zhang, Bo Shao, Qin Dang, Zhuang Chen, Quanbo Zhou, Hong Luo, Weitang Yuan, Zhenqiang Sun · 2021 · Frontiers in Immunology
99. Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance
    Rudolf Lucas, Yalda Hadizamani, Perenlei Enkhbaatar, Gábor Csányi, Robert W. Caldwell, Harald Hundsberger, Supriya Sridhar, Alice Ann Lever, Martina Hudel, Dipankar Ash et al. · 2022 · Frontiers in Physiology
100. T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID
     Lavanya Visvabharathy, Barbara Ann Hanson, Zachary S. Orban, Patrick H. Lim, Nicole M. Palacio, Millenia Jimenez, Jeffrey R. Clark, Edith L. Graham, Eric Michael Liotta, George Tachas et al. · 2021 · medRxiv